1.Are we ready for prostate cancer?
Chinese Medical Journal 2008;121(4):291-291
China
;
epidemiology
;
Humans
;
Male
;
Prostatic Neoplasms
;
epidemiology
;
genetics
;
surgery
2.Incidence of kidney, bladder, and prostate cancers in Korea: An update.
Korean Journal of Urology 2015;56(6):422-428
The incidence of cancer is sharply increasing. Cancer is a leading cause of death as well as a significant burden on society. The incidence of urological cancer has shown a higher than average increase and will become an important concern in the future. Therefore, an overall and accurate understanding of the incidence of urological cancer is essential. In this study, which was based on the Korea National Cancer Incidence Database, annual incident cases, age-standardized incidence rates, annual percentage change (APC), and distribution by age group were examined in kidney, bladder, and prostate cancers, respectively. From 1999 to 2011, the total number of each type of urological cancer was as follows: kidney cancer (32,600 cases, 25.5%), bladder cancer (37,950 cases, 29.7%), and prostate cancer (57,332 cases, 44.8%). The age-standardized incidence rates of prostate cancer showed a significant increase with an APC of 12.3% in males. Kidney cancer gradually increased with an APC of 6.0% for both sexes and became the second most frequent urological cancer after 2008. Bladder cancer showed no significant change with an APC of -0.2% for both sexes and has decreased slightly since 2007. The distribution of kidney cancer according to age showed two peaks in the 50- to 54-year-old and 65- to 69-year-old age groups. Bladder and prostate cancers occurred mostly in the 70- to 74-year-old age group. The proportions of male to female were 2.5:1 in kidney cancer and 5.6:1 in bladder cancer. We have summarized the incidence trends of kidney, bladder, and prostate cancers and have provided useful information for screening and management of these cancers in the future.
Female
;
Humans
;
Incidence
;
Kidney Neoplasms/epidemiology
;
Male
;
Prostatic Neoplasms/epidemiology
;
Republic of Korea/epidemiology
;
Urinary Bladder Neoplasms/epidemiology
;
Urogenital Neoplasms/*epidemiology
3.Significance of atypical small acinar proliferation and high-grade prostatic intraepithelial neoplasia in prostate biopsy in China.
National Journal of Andrology 2021;27(9):798-802
Objective:
To assess the rates of atypical small acinar proliferation (ASAP) and high-grade prostatic intraepithelial neoplasia (HGPIN) detected in prostate biopsy in China and the risk of PCa found in subsequent repeat biopsy.
METHODS:
A total of 2,456 patients underwent TRUS-guided prostate biopsy with the samples of ASAP and/or HGPIN tissues in our hospital at least twice between July 2014 and June 2019. We analyzed the findings of digital rectal examination, prostate volumes, PSA levels, and the results of prostate biopsies.
RESULTS:
Initial prostate biopsies revealed 737 cases of PCa (30.0%), 215 cases of ASAP (8.8%), 98 cases of HGPIN (4.0%), and 18 cases of ASAP+HGPIN (0.7%). Totally, 313 of the patients met the inclusion criteria and included in this study. Of the 215 cases of ASAP confirmed in the first biopsy, 72 and 25 were diagnosed with PCa in the second and third biopsies, respectively, 83 with Gleason score (GS) 6, 14 with GS7, 57 with T1c and 40 with T2a tumors. Of the 98 cases of HGPIN confirmed in the first biopsy, 1 was diagnosed with PCa in the second and another 1 in the third biopsy, both with GS6 and T1c tumors. Of the 18 cases of ASAP+HGPIN confirmed in the first biopsy, 7 and 3 were diagnosed with PCa in the second and third biopsies, respectively, 7 with GS6, 3 with GS7, 6 with T1c and 4 with T2a tumors.
CONCLUSIONS
ASAP is a significant risk factor for PCa and repeat prostate biopsy should be performed for patients diagnosed with ASAP in the first biopsy. Whether repeat biopsy is necessary for those diagnosed with HGPIN depends on other related clinical parameters./.
Biopsy
;
Cell Proliferation
;
China/epidemiology*
;
Humans
;
Male
;
Prostate
;
Prostatic Intraepithelial Neoplasia
;
Prostatic Neoplasms
4.Explaining Cancer Incidence in the Jejudo Population.
Journal of Preventive Medicine and Public Health 2009;42(1):67-72
OBJECTIVES: Using the population-based cancer registry in Jejudo, we found that Jejudo had lower incidence in stomach cancer than other regions in Korea. The aim of this study was to evaluate reasons for this difference. METHODS: Citrus is the leading agricultural production in Jejudo, suggesting that lower cancer incidence in Jejudo could be explained by citrus fruit intake. We evaluated this hypothesis with quantitative systematic review (QSR). RESULTS: Stomach cancer incidence was significantly lower, with a summary odds ratio (SOR) after QSR of 0.72 [95% CI=0.64-0.81]. In addition, the SOR of pancreatic cancer tended to be lower at 0.83 [95% CI=0.70-0.98]. The SOR of prostate cancer was slightly higher at 1.03 [0.89-1.19]. CONCLUSIONS: Quantitative systematic reviews for the effect of citrus fruit intake on cancer occurrence suggested that lower cancer incidence in Jejudo could be explained by intake of citrus fruits.
*Citrus
;
Female
;
Humans
;
Incidence
;
Korea/epidemiology
;
Male
;
Neoplasms/*epidemiology
;
Odds Ratio
;
Pancreatic Neoplasms/epidemiology
;
Prostatic Neoplasms/epidemiology
;
*Registries
;
Stomach Neoplasms/epidemiology
5.Epidemiology of prostate cancer in China: an overview and clinical implication.
Chinese Journal of Surgery 2015;53(4):249-252
Prostate cancer is a currently common disease in Chinese male. The incidence is increasing rapidly in urban area and the mortality is high in rural area. According to characteristics of disease stage, advancement in early diagnosis of prostate cancer is the key to improve prostate cancer survival in China. Because of the remarkable disparity in economic and health care across mainland China, a selective prostate cancer screen approach may be a better alternative to spread. Therefore, indepth researches in optimization of prostate specific antigen screen and validation biomarkers of aggressive prostate cancer should be advocated. Furthermore, physicians should take a more active role in population education.
China
;
epidemiology
;
Early Detection of Cancer
;
Humans
;
Incidence
;
Male
;
Prostate-Specific Antigen
;
blood
;
Prostatic Neoplasms
;
diagnosis
;
epidemiology
6.China guideline for the screening and early detection of prostate cancer (2022, Beijing).
Jie HE ; Wan Qing CHEN ; Ni LI ; Wei CAO ; Ding Wei YE ; Jian Hui MA ; Nian Zeng XING ; Ji PENG ; Jin Hui TIAN
Chinese Journal of Oncology 2022;44(1):29-53
Prostate cancer (PC) is one of the malignant tumors of the genitourinary system that occurs more often in elderly men. Screening, early diagnosis, and treatment of the PC high risk population are essential to improve the cure rate of PC. The development of the guideline for PC screening and early detection in line with epidemic characteristics of PC in China will greatly promote the homogeneity and quality of PC screening. This guideline was commissioned by the Bureau of Disease Control and Prevention of the National Health Commission. The National Cancer Center of China initiated and convened a working group comprising multidisciplinary experts. This guideline strictly followed the World Health Organization Handbook for Guideline Development and combined the most up-to-date evidence of PC screening, China's national conditions, and practical experience in cancer screening. A total of fifteen detailed evidence-based recommendations were provided with respect to the screening population, technology, procedure management, and quality control in the process of PC screening. This guideline aimed to standardize the practice of PC screening and improve the effectiveness and efficiency of PC prevention and control in China.
Aged
;
Beijing
;
China/epidemiology*
;
Early Detection of Cancer
;
Humans
;
Male
;
Mass Screening
;
Prostatic Neoplasms/epidemiology*
7.Correlation of high-risk HPV 16/18 infections with prostate cancer.
Lin HUANG ; Ming-Gui WU ; Juan HE ; Zheng-Shu WEI ; Wen-Xin LÜ ; Xu-Jia SONG ; Yan ZHANG ; Shang-Xin WU ; You-le YIN ; Yong-Yi FAN
National Journal of Andrology 2016;22(6):501-505
ObjectiveTo study the correlation of high-risk human papillomavirus 16 and 18 (HPV16/18) infections with the risk of prostate cancer (PCa) and their association with the clinicopathologic indexes of PCa.
METHODSWe collected tissue samples from 75 cases of PCa and 73 cases of benign prostatic hyperplasia (BPH). We detected HPV16/18 infections in the samples by immunohistochemistry and PCR combined with reverse dot blot (RDB) assay.
RESULTSImmunohistochemistry revealed 16 cases of HPV16/18 positive in the PCa (21.3%) and 7 cases in the BPH samples (9.5%), with statistically significant difference between the two groups (P=0.049). PCR combined with RDB assay showed 17 cases of HPV16 infection (22.6%) and 13 cases of HPV18 infection (17.8%), including 4 cases of HPV16/18 positive, in the PCa group, remarkably higher than 6 cases of HPV16 infection (8.2%), 3 cases of HPV18 infection (4.1%) and no HPV16/18 positive in the BPH controls (P=0.001). No significant differences were observed between the result of immunohistochemistry and that of PCR combined with RDB assay (P=0.069). The risk of HPV16/18 infections was found to be correlated with the clinical T-stage and Gleason score of PCa (P<0.05 ) but not with the patient's age, PSA level or lymph node metastasis (P>0.05 ).
CONCLUSIONSHigh-risk HPV16/18 infections are correlated with the risk of prostate cancer.
Human papillomavirus 16 ; Human papillomavirus 18 ; Humans ; Immunohistochemistry ; Lymphatic Metastasis ; Male ; Neoplasm Grading ; Papillomavirus Infections ; epidemiology ; Polymerase Chain Reaction ; Prostatic Hyperplasia ; epidemiology ; virology ; Prostatic Neoplasms ; epidemiology ; virology
8.Assessment of the physical status of elderly patients with prostate cancer.
National Journal of Andrology 2017;23(12):1132-1137
Prostate cancer (PCa) is the primary malignancy threatening men's health in the United States and its incidence is increasing in China year by year. Many PCa cases are found in the advanced stage or in the old age, treated with unstandardized options, with negligence of comprehensive assessment of the patient's physical status, which may frequently add to the physical, psychological and economic burdens of the patient and even result in death. On the other hand, some excessively conservative therapeutic options may cause the loss of the best time of management or lead to deterioration of the disease. Therefore, sufficient importance should be attached to the comprehensive assessment of the physical status of the elderly PCa patient before treatment and the choice of the best therapeutic protocol.
Aged
;
China
;
epidemiology
;
Conservative Treatment
;
Humans
;
Incidence
;
Male
;
Physical Fitness
;
Prostatic Neoplasms
;
epidemiology
;
pathology
;
therapy
;
United States
;
epidemiology
9.News Portrayal of Cancer: Content Analysis of Threat and Efficacy by Cancer Type and Comparison with Incidence and Mortality in Korea.
Minsun SHIM ; Yong Chan KIM ; Su Yeon KYE ; Keeho PARK
Journal of Korean Medical Science 2016;31(8):1231-1238
How the news media cover cancer may have profound significance for cancer prevention and control; however, little is known about the actual content of cancer news coverage in Korea. This research thus aimed to examine news portrayal of specific cancer types with respect to threat and efficacy, and to investigate whether news portrayal corresponds to actual cancer statistics. A content analysis of 1,138 cancer news stories was conducted, using a representative sample from 23 news outlets (television, newspapers, and other news media) in Korea over a 5-year period from 2008 to 2012. Cancer incidence and mortality rates were obtained from the Korean Statistical Information Service. Results suggest that threat was most prominent in news stories on pancreatic cancer (with 87% of the articles containing threat information with specific details), followed by liver (80%) and lung cancers (70%), and least in stomach cancer (41%). Efficacy information with details was conveyed most often in articles on colorectal (54%), skin (54%), and liver (50%) cancers, and least in thyroid cancer (17%). In terms of discrepancies between news portrayal and actual statistics, the threat of pancreatic and liver cancers was overreported, whereas the threat of stomach and prostate cancers was underreported. Efficacy information regarding cervical and colorectal cancers was overrepresented in the news relative to cancer statistics; efficacy of lung and thyroid cancers was underreported. Findings provide important implications for medical professionals to understand news information about particular cancers as a basis for public (mis)perception, and to communicate effectively about cancer risk with the public and patients.
Communication
;
Humans
;
Incidence
;
Internet/statistics & numerical data
;
Liver Neoplasms/epidemiology
;
Male
;
Mass Media/*statistics & numerical data
;
Neoplasms/*epidemiology/mortality/prevention & control
;
Pancreatic Neoplasms/epidemiology
;
Prostatic Neoplasms/epidemiology
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Stomach Neoplasms/epidemiology
10.News Portrayal of Cancer: Content Analysis of Threat and Efficacy by Cancer Type and Comparison with Incidence and Mortality in Korea.
Minsun SHIM ; Yong Chan KIM ; Su Yeon KYE ; Keeho PARK
Journal of Korean Medical Science 2016;31(8):1231-1238
How the news media cover cancer may have profound significance for cancer prevention and control; however, little is known about the actual content of cancer news coverage in Korea. This research thus aimed to examine news portrayal of specific cancer types with respect to threat and efficacy, and to investigate whether news portrayal corresponds to actual cancer statistics. A content analysis of 1,138 cancer news stories was conducted, using a representative sample from 23 news outlets (television, newspapers, and other news media) in Korea over a 5-year period from 2008 to 2012. Cancer incidence and mortality rates were obtained from the Korean Statistical Information Service. Results suggest that threat was most prominent in news stories on pancreatic cancer (with 87% of the articles containing threat information with specific details), followed by liver (80%) and lung cancers (70%), and least in stomach cancer (41%). Efficacy information with details was conveyed most often in articles on colorectal (54%), skin (54%), and liver (50%) cancers, and least in thyroid cancer (17%). In terms of discrepancies between news portrayal and actual statistics, the threat of pancreatic and liver cancers was overreported, whereas the threat of stomach and prostate cancers was underreported. Efficacy information regarding cervical and colorectal cancers was overrepresented in the news relative to cancer statistics; efficacy of lung and thyroid cancers was underreported. Findings provide important implications for medical professionals to understand news information about particular cancers as a basis for public (mis)perception, and to communicate effectively about cancer risk with the public and patients.
Communication
;
Humans
;
Incidence
;
Internet/statistics & numerical data
;
Liver Neoplasms/epidemiology
;
Male
;
Mass Media/*statistics & numerical data
;
Neoplasms/*epidemiology/mortality/prevention & control
;
Pancreatic Neoplasms/epidemiology
;
Prostatic Neoplasms/epidemiology
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Stomach Neoplasms/epidemiology